India's Vaccine Manufacturer Says To File $13.5Mln Countersuit Against Trial Volunteer
Faizan Hashmi Published November 30, 2020 | 11:40 AM
NEW DELHI (UrduPoint News / Sputnik - 30th November, 2020) The Serum Institute of India has said that it will see seek 1 billion rupees ($13.5 million) in countersuit against a volunteer in trials of Oxford's COVID-19 vaccine Covishield for "falsely laying the blame for his medical problems" on the jab.
A 40-year-old Chennai resident, who was administered the vaccine on October 1, has filed a legal notice, complaining that he began experiencing "severe headaches", "total behavioural change" and "irritation towards light and sound" 10 days after the inoculation. In late October, he was discharged from hospital after suffering from "acute encephalopathy," which he claims was "an extreme side effect of the test vaccine."
"The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer's medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer. The volunteer is falsely laying the blame for his medical problems on the COVID vaccine trial," the Serum Institute told the NDTV channel in a statement on Sunday evening.
According to the vaccine manufacturer, "the claim is malicious because the volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent."
"In spite of specifically being made aware of the same, he still chose to go public and malign the reputation of the company," the statement read, adding that it would defend itself in court.
Trials for several COVID-19 vaccine candidates are currently underway in India. The Serum Institute of India is conducting phase 3 trials of Bharat Biotech's Covaxin and Oxford's Covishield. In addition, the ZycovD vaccine pharmaceutical company Zydus Cadila and a vaccine developed by Biological E. Limited, US-based Dynavax Technologies Corp and Baylor College of Medicine are also at the trial stage. Trials for Russia's Sputnik V are to set to begin this week.
Recent Stories
Under training officers visit Special Branch Headquarters Roberts Club
Industries promotion can help eliminate unemployment : Sindh Minister for Indus ..
Step afoot to ensure durable peace in Balochistan: Ziuallah
PML-N office torching cases: ATC summons PTI leaders, others for indictment on M ..
Oman, UAE deluge 'most likely' linked to climate change: scientists
CRBC tender to be floated by June; Chief Minister Khyber Pakhtunkhwa Sardar Ali ..
122 cases registered against accused involved in drug trafficking
Models, poster and quiz competition held at AIOU
Passco GM, deputy visit wheat procurement centers in Burewala
Non-Muslim Pakistanis enjoy freedom, state patronage: Kundi
Dengue Control Committee gathers in Jhang
BHP launches $38.8 billion takeover bid for rival Anglo American
More Stories From World
-
Oman, UAE deluge 'most likely' linked to climate change: scientists
17 minutes ago -
BHP launches $38.8 billion takeover bid for rival Anglo American
27 minutes ago -
Saudi oil giant Aramco agrees major FIFA sponsorship deal
27 minutes ago -
Putin says plans to visit China in May
27 minutes ago -
Haiti transitional council sworn in after months of violence
1 hour ago -
Ukrainian village battles mines year after Russia forced out
2 hours ago
-
China's Shenzhou-18 mission takes off bound for space station
1 hour ago -
Thousands of flights scrapped as French air traffic controllers strike
1 hour ago -
India's IndiGo to buy 30 A350 planes: Airbus
1 hour ago -
Scottish leader scraps coalition deal with Greens
2 hours ago -
Paris landmark Moulin Rouge's windmill sails collapse
2 hours ago -
155 killed in Tanzania as heavy rains lash East Africa
2 hours ago